Saturday 26 November 2022 10:08 PM Drug marked as 'beginning of the end for dementia' in doubt over brain bleed ... trends now
Lecanemab, which has been trialed across America, was found to drastically slow the disease's progression. And last week, Professor John Hardy, a world-leading dementia researcher at University College London (UCL) – whose original research paved the way to creating lecanemab – made headlines when he said he hoped the drug would be available on the NHS in a year.
But speaking to The Mail on Sunday, he warned that prescribing lecanemab has risks which could dramatically hike its costs.
One in ten patients in the